{"id":47737,"date":"2022-08-29T12:01:56","date_gmt":"2022-08-29T10:01:56","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/"},"modified":"2022-08-29T12:01:56","modified_gmt":"2022-08-29T10:01:56","slug":"revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/","title":{"rendered":"Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022"},"content":{"rendered":"
\n

VANCOUVER, British Columbia–(BUSINESS WIRE)–#education<\/a>–REVITALIST LIFESTYLE AND WELLNESS LTD. (\u201cRevitalist\u201d or the \u201cCompany\u201d) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), a Veteran and Nurse lead ketamine wellness company, is pleased to report updated company structures aligning the mission of the company for aggressive strategic growth opportunities in the psychedelic wellness field.\n<\/p>\n

<\/a><\/p>\n

\nRevitalist CEO, Kathryn Walker states, \u201cRevitalist continues to excel in an unprecedented manner leading to expansive opportunities in the psychedelic wellness space. While we greatly appreciate the inaugural board members, Patrick Gray and Aaron Bowden, we have accepted their resignation as of August 18, 2022.\n<\/p>\n

\nWe are grateful to welcome Corby Marshall and Kevin Murray as incoming board members. Mr. Marshall comes to Revitalist as a West Point graduate with expansive experience allowing us to have a distinguished community leader aggressively expanding our mission for veterans while keeping a \u201ctrue north\u201d mission.\n<\/p>\n

\nMr. Murray\u2019s decades of specialized global finance experience allows us the capacity to move aggressively in a realm of financial opportunities helping us to diversify our revenue streams in various capacities leading to exponential growth.\n<\/p>\n

\nThe future is just beginning and we are grateful to be a part of it.\u201d\n<\/p>\n

\nOn Behalf of the Board\n<\/p>\n

\nKathryn Walker\n<\/p>\n

\nChief Executive Officer\n<\/p>\n

\nTwitter: @RevitalistCorp<\/a>\n<\/p>\n

\nFacebook: @RevitalistLifestyleandWellnessLtd.<\/a>\n<\/p>\n

\nInstagram: @RevitalistCorp<\/a>\n<\/p>\n

\nLinkedIn: @RevitalistLifestyleAndWellnessLtd<\/a>\n<\/p>\n

\nForward Looking Statements<\/i><\/b>\n<\/p>\n

\nThis news release contains forward-looking statements and information within the meaning of applicable securities legislation. Forward looking statements or information involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Revitalist to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements or information contained in this news release.<\/i>\n<\/p>\n

\nRisks, uncertainties, and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information. The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nFor further information please contact:
\n
Revitalist Lifestyle and Wellness Ltd.
\n
Email: Info@Revitalist.com<\/a>
Tel: (865) 585-8414\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–REVITALIST LIFESTYLE AND WELLNESS LTD. (\u201cRevitalist\u201d or the \u201cCompany\u201d) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), a Veteran and Nurse lead ketamine wellness company, is pleased to report updated company structures aligning the mission of the company for aggressive strategic growth opportunities in the psychedelic wellness field. Revitalist CEO, Kathryn Walker states, \u201cRevitalist … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-47737","6":"format-standard","7":"category-industry"},"yoast_head":"\nRevitalist Updates Infrastructure for Aggressive Growth Strategy in 2022 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–REVITALIST LIFESTYLE AND WELLNESS LTD. (\u201cRevitalist\u201d or the \u201cCompany\u201d) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), a Veteran and Nurse lead ketamine wellness company, is pleased to report updated company structures aligning the mission of the company for aggressive strategic growth opportunities in the psychedelic wellness field. Revitalist CEO, Kathryn Walker states, \u201cRevitalist ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-08-29T10:01:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220829005251\/en\/1555105\/21\/Revitalist_LOGO.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022\",\"datePublished\":\"2022-08-29T10:01:56+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/\"},\"wordCount\":358,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005251\\\/en\\\/1555105\\\/21\\\/Revitalist_LOGO.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/\",\"name\":\"Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005251\\\/en\\\/1555105\\\/21\\\/Revitalist_LOGO.jpg\",\"datePublished\":\"2022-08-29T10:01:56+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005251\\\/en\\\/1555105\\\/21\\\/Revitalist_LOGO.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220829005251\\\/en\\\/1555105\\\/21\\\/Revitalist_LOGO.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/","og_locale":"en_US","og_type":"article","og_title":"Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022 - Pharma Trend","og_description":"VANCOUVER, British Columbia–(BUSINESS WIRE)–#education–REVITALIST LIFESTYLE AND WELLNESS LTD. (\u201cRevitalist\u201d or the \u201cCompany\u201d) (CSE: CALM) (OTCQB: RVLWF) (FSE: 4DO), a Veteran and Nurse lead ketamine wellness company, is pleased to report updated company structures aligning the mission of the company for aggressive strategic growth opportunities in the psychedelic wellness field. Revitalist CEO, Kathryn Walker states, \u201cRevitalist ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/","og_site_name":"Pharma Trend","article_published_time":"2022-08-29T10:01:56+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220829005251\/en\/1555105\/21\/Revitalist_LOGO.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022","datePublished":"2022-08-29T10:01:56+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/"},"wordCount":358,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005251\/en\/1555105\/21\/Revitalist_LOGO.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/","url":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/","name":"Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220829005251\/en\/1555105\/21\/Revitalist_LOGO.jpg","datePublished":"2022-08-29T10:01:56+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220829005251\/en\/1555105\/21\/Revitalist_LOGO.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220829005251\/en\/1555105\/21\/Revitalist_LOGO.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/revitalist-updates-infrastructure-for-aggressive-growth-strategy-in-2022\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Revitalist Updates Infrastructure for Aggressive Growth Strategy in 2022"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47737","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=47737"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/47737\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=47737"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=47737"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=47737"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}